Evidence map›Paper›PMID 37305389›Full record

ArticleOncology research2023

Apolipoprotein C1 promotes tumor progression in gastric cancer.

Qiou Gu, Tian Zhan, Xiao Guan, Chuilin Lai, N A Lu, Guoguang Wang, Lei Xu, Xiang Gao, Jianping Zhang

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. A simplified MyProstateScore2.0 for high-grade prostate cancer.Cancer biomarkers : section A of Disease markers · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Qiou GuDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Tian ZhanDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Xiao GuanDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Chuilin LaiDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
N A LuDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Guoguang WangDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Lei XuDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Xiang GaoDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Jianping ZhangDepartment of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Second Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) is a malignancy with the worst prognosis that seriously threatens human health, especially in East Asia. Apolipoprotein C1 ( Methods: Firstly, we quantified its expression in GC and adjacent tumor tissues, using The Cancer Genome Atlas (TCGA). Next, we assessed cell invasion and migration abilities. Finally, we revealed the role of Results: Firstly, in TCGA database, it has been shown that elevated expression of Conclusions: These results suggest that

Indexed as

Stomach NeoplasmsApolipoprotein C-IHumansImmunotherapyTumor MicroenvironmentApolipoprotein C-IApolipoprotein C1Drug sensitivityGastric cancerImmune cell infiltrationTME

Identifiers

PMID37305389
PMCPMC10229309
OpenAlexW4372079604

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.